Displaying 21 to 40 of 104 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
China Cord Blood Corp Leads in the Chinese cord blood collection industry |
China | N/A |
||
|
|
Chroma Therapeutics Ltd Focused on harnessing the power of chromatin biology and novel drug accumulation approaches to discover and develop a new generation of targeted cance |
United Kingdom | N/A Active |
||
|
|
Clear Vascular Inc Developer of innovative cardiovascular products |
United States | N/A |
||
|
Complete Genomics Inc |
United States | 1 Aug 2010 | Series E Active |
|
|
|
Complete Genomics Inc |
United States | 1 Aug 2009 | Series D Active |
|
|
|
Confluent Surgical Inc A medical device company leading in the field of surgical sealants and adhesion barriers for use in neurosurgery, gynecologic and general surgery. |
United States | 1 Mar 2005 | Series D |
|
|
|
Confluent Surgical Inc A medical device company leading in the field of surgical sealants and adhesion barriers for use in neurosurgery, gynecologic and general surgery. |
United States | 1 Jun 2002 | Series C |
|
|
|
Cord Blood Registry Collects, processes and cryogenically freezes storage of stem cells |
United States | N/A |
||
|
|
Corium International Inc |
United States | N/A |
||
|
|
Curis Inc Develops innovative therapeutics targeting cancer network disruption |
United States | N/A |
||
|
|
Dow Pharmaceutical Sciences LLC |
United States | N/A |
||
|
|
Echo Therapeutics Develops needle-free, wireless, transdermal continuous glucose monitoring system. |
United States | N/A |
||
|
|
Elusys Therapeutics Inc Develops antibody-based therapies to treat infectious diseases. |
United States | N/A |
||
|
|
Endologix Inc Develops and manufactures minimally invasive treatments for vascular diseases. |
United States | N/A |
||
|
Entellus Medical Inc Developer of innovative device technology and treatment to address the unmet needs of ENT physicians and their patients. |
United States | 1 Oct 2011 | Series E Active |
|
|
|
Entellus Medical Inc Developer of innovative device technology and treatment to address the unmet needs of ENT physicians and their patients. |
United States | 1 Nov 2009 | Series D Active |
|
|
|
EUSA Pharma Inc Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care |
United States | N/A |
||
|
|
Health Grades Inc Provides reports and ratings to guide patients to better care providers |
United States | N/A |
||
|
|
Healthcare Brands Intl Ltd Committed to translating innovative science into meaningful consumer brands. Sold subsidiary, Antula Healthcare, for SEK 1.8bn in April 2011. |
United Kingdom | N/A |
||
|
|
HealthHelp Inc A leading specialty benefit management services company to health care payers. |
United States | N/A |